SEC Comment Letter 0000000000-23-000191 to Pear Therapeutics, Inc. (CIK 0001835567)
Pear Therapeutics, Inc. (CIK 0001835567)
Date: Jan. 6, 2023 · CIK: 0001835567 · Accession: 0000000000-23-000191
AI Filing Summary & Sentiment
File numbers found in text: 333-269097
Letter
United States securities and exchange commission logo January 6, 2023 Corey McCann Chief Executive Officer Pear Therapeutics, Inc. 200 State Street, 13th Floor Boston, MA 02109 Re:Pear Therapeutics, Inc. Registration Statement on Form S-3 Filed January 3, 2023 File No. 333-269097 Dear Corey McCann: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Benjamin Richie at 202-551-7857 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Stacie S. Aarestad
Show Raw Text
United States securities and exchange commission logo
January 6, 2023
Corey McCann
Chief Executive Officer
Pear Therapeutics, Inc.
200 State Street, 13th Floor
Boston, MA 02109
Re:Pear Therapeutics, Inc.
Registration Statement on Form S-3
Filed January 3, 2023
File No. 333-269097
Dear Corey McCann:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Benjamin Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Stacie S. Aarestad